Research Article | Volume: 6, Issue: 5, May, 2016

Formulation and Evaluation of Nanoscale Solid Lipid Particles Containing a Hydrophilic Drug-Rasagiline Mesylate

Viveksarathi Kunasekaran Kannan Krishnamoorthy   

Open Access   

Published:  May 28, 2016

DOI: 10.7324/JAPS.2016.60507

The present study was to prepare and characterize Rasagiline mesylate loaded nanoscale solid lipid particles and evaluate its In-vitro release. Rasagiline mesylate loaded solid lipid nanoparticles was fabricated by microemulsion technique and then characterized with respect to particle size, polydispersity index and zeta potential were measured by photon correlation spectroscopy. Morphological examination was visualized by transmission electron microscopy. The release of Rasagiline mesylate from solid lipid nanoparticles was performed by using the incubator shaking technique. The fabricated formulations particle size ranged from 160.20±3.2 to 210.12±5.3 nm and the zeta potential measurements indicates a narrow size distribution. The Polydispersity index values shown narrow that means the nanoparticles are homogenous in nature. Drug loading and entrapment efficiency of RMSLN-I & RMSLN-II were 33.34±1.45 % & 76.24±1.2 % and 16.67±0.86 % & 73.75±1.02 %, respectively. TEM revealed the particles were monodisperse, uniform size and quasispherical shape. Release of Rasagiline mesylate loaded nanoscale solid lipid particles were shown efficient prolonged drug release and followed by Fickian diffusion mechanism. Furthermore, RM loaded SLNs were found to be stable, after 6 months of storage at different conditions. The developed solid lipid nanoparticles were able to control the drug release for a prolonged period of time.

Keyword:     Parkinson disease Rasagiline mesylate Solid lipid nanoparticles Scanning electron microscopy Transmission electron microscopy.


Kunasekaran V, Krishnamoorthy K. Formulation and Evaluation of Nanoscale Solid Lipid Particles Containing a Hydrophilic Drug - Rasagiline Mesylate. J App Pharm Sci, 2016; 6 (05): 044-050.

Copyright:The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text


Article Metrics
329 Views 35 Downloads 364 Total



Related Search

By author names